| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -4% |
| 3Y CAGR | +6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -92% |
| 3Y CAGR | +6% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,520.30 +17.80 (0.71%) | 19,010.91 | 28.04 | 5.64 | ||
PfizerPFIZER | ₹3,893.30 -24.60 (0.63%) | 17,930.59 | 20.86 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,507.00 -7.50 (0.12%) | 16,280.50 | 91.61 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹808.95 +4.60 (0.57%) | 15,772.88 | 13.78 | 1.5 |